Back to Search
DAVID HARDIN, MD
MD
Surgery Physician
NPI: 1639174907Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Statement 6: patients who are unresponsive to GH therapy should be given a trial of IGF-I.
PMID 18438330·Pediatr Endocrinol Rev·2008
6-review
Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes.
PMID 18418124·J Investig Med·2008
8-other
A review of the management of two common clinical problems found in patients with cystic fibrosis: cystic fibrosis-related diabetes and poor growth.
PMID 18174725·Horm Res·2007
6-review
Twenty years of recombinant human growth hormone in children: relevance to pediatric care providers.
PMID 17475983·Clin Pediatr (Phila)·2007
6-review
Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
PMID 17201806·Clin Endocrinol (Oxf)·2007
8-other
Insulin-like growth factor-I levels predict weight, height and protein catabolism in children and adolescents with cystic fibrosis.
PMID 19618660·J Pediatr Endocrinol Metab·2009
4-observational
Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.
PMID 19279441·AIDS·2009
4-observational
Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes.
PMID 19564474·Diabetes Care·2009
4-observational
Use of the insulin pump in treat cystic fibrosis related diabetes.
PMID 19162566·J Cyst Fibros·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9399 CROWN CREST BLVD, SUITE 430
PARKER, CO 80138 - Phone
- (303) 269-2310
Quick Facts
- NPI
- 1639174907
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile